-
Lorcaserin,
marketed under the
brand name Belviq, was a weight-loss drug
developed by
Arena Pharmaceuticals. It
reduces appetite by
activating serotonin...
- derivatives, such as
Lorcaserin (Figure 6) have been
evaluated for
their potency and
selectivity for the 5-HT2C receptors.
Lorcaserin is a very
potent agonist...
- on the market,
Belviq (
lorcaserin), a weight-loss medication. The U.S. Food and Drug
Administration (FDA)
approved lorcaserin on June 27, 2012. The company...
-
Michele (May 8, 2013). "Schedules of
Controlled Substances:
Placement of
Lorcaserin Into
Schedule IV".
Federal Register. Drug
Enforcement Administration....
- its
potential for
causing valvulopathies and
pulmonary hypertension)
Lorcaserin (withdrawn in the
United States by the FDA due to an
increased risk of...
-
serotonin receptors in a
region of the
brain called the hypothalamus.
Lorcaserin (Belviq) was FDA
approved for
weight loss but was
withdrawn from the market...
- It is
being developed by
Longboard Pharmaceuticals. BMB-101
Clemizole Lorcaserin Vabicaserin "Bexicaserin -
Longboard Pharmaceuticals". AdisInsight. 16...
- as fenfluramine, dexfenfluramine, chlorphentermine, sibutramine, and
lorcaserin, have been
approved and used as
appetite suppressants for
purposes of...
-
authorities rejected lorcaserin and phentermine-topiramate, in part
because of ****ociations of
heart valve problems with
lorcaserin and more
general heart...
-
loratadine (INN)
Loraz lorazepam (INN)
lorbamate (INN)
lorcainide (INN)
lorcaserin (USAN) Lorcet-HD
lorcinadol (INN)
loreclezole (INN)
Loreev XR Lorelco...
